The first patient has been treated in a pivotal clinical trial of Simplify Medical’s Simplify® cervical disc, investigating use in two adjacent levels to treat degenerative disc disease.
The prospective, randomized controlled trial will enroll up to 215 patients at up to 15 centers, comparing implantation of two contiguous discs from C3 to C7 with 2-level cervical fusion.
Comprising PEEK-on-ceramic materials, Simplify is designed to be clearly viewed on MRI with minimal artifact, potentially protecting patients from radiation associated with CT scans, which have been shown to expose patients to ionizing radiation that equates to 400 to 550 chest x-rays per scan.
The first patient has been treated in a pivotal clinical trial of Simplify Medical's Simplify® cervical disc, investigating use in two adjacent levels to treat degenerative disc disease.
The first patient has been treated in a pivotal clinical trial of Simplify Medical’s Simplify® cervical disc, investigating use in two adjacent levels to treat degenerative disc disease.
The prospective, randomized controlled trial will enroll up to 215 patients at up to 15 centers, comparing implantation of two contiguous discs from C3 to C7 with 2-level cervical fusion.
Comprising PEEK-on-ceramic materials, Simplify is designed to be clearly viewed on MRI with minimal artifact, potentially protecting patients from radiation associated with CT scans, which have been shown to expose patients to ionizing radiation that equates to 400 to 550 chest x-rays per scan.
Copy to clipboard 
